Aripiprazole 5 mg - search results

United States - English - NLM (National Library of Medicine)

aripiprazole tablet

solco healthcare u.s., llc - aripiprazole (unii: 82vfr53i78) (aripiprazole - unii:82vfr53i78) - aripiprazole 2 mg - aripiprazole tablets are indicated for the treatment of: aripiprazole is contraindicated in patients with a history of a hypersensitivity reaction to aripiprazole. reactions have ranged from pruritus/urticaria to anaphylaxis [see adverse reactions (6.2)] . pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to atypical antipsychotics, including aripiprazole, during pregnancy. healthcare providers are encouraged to register patients by contacting the national pregnancy registry for atypical antipsychotics at 1-866-961-2388 or visit http://womensmentalhealth.org/clinical-and-research-programs/pregnancyregistry/. risk summary neonates exposed to antipsychotic drugs, including aripiprazole, during the third trimester of pregnancy are at risk for extrapyramidal and/or withdrawal symptoms following delivery (see clinical considerations) . overall available data from published epidemiologic studies of pregnant women exposed to aripiprazole have not est

New Zealand - English - Medsafe (Medicines Safety Authority)

apo-aripiprazole

apotex nz ltd - aripiprazole 5mg - tablet - 5 mg - active: aripiprazole 5mg excipient: croscarmellose sodium indigo carmine aluminium lake magnesium stearate microcrystalline cellulose tartaric acid - indicated for the treatment of schizophrenia including maintenance of clinical improvement during continuation therapy.

New Zealand - English - Medsafe (Medicines Safety Authority)

apo-aripiprazole

apotex nz ltd - aripiprazole 15mg - tablet - 15 mg - active: aripiprazole 15mg excipient: carmellose iron oxide yellow magnesium stearate microcrystalline cellulose tartaric acid - indicated for the treatment of schizophrenia including maintenance of clinical improvement during continuation therapy.